Bliss GVS Pharma has informed that Board Meeting of the Company was held on Monday, November 11, 2019 at the registered office of the Company. The Board has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2019. A copy of unaudited financial results along with the Limited Review Report of the Auditor of the Company are enclosed herewith as Annexure-I. The meeting of the Board of Directors commenced at 6.30 pm and concluded at 9.15 pm.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1679.85 |
| Dr. Reddys Lab | 1333.05 |
| Cipla | 1305.85 |
| Zydus Lifesciences | 947.10 |
| Lupin | 2340.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: